UnitedHealth Group Inc (UNH) is Meiji Yasuda Life Insurance Co’s 9th Largest Position

Meiji Yasuda Life Insurance Co grew its position in UnitedHealth Group Inc (NYSE:UNH) by 1.6% in the 3rd quarter, Holdings Channel reports. The firm owned 32,381 shares of the healthcare conglomerate’s stock after buying an additional 510 shares during the period. UnitedHealth Group makes up approximately 1.1% of Meiji Yasuda Life Insurance Co’s investment portfolio, making the stock its 9th largest position. Meiji Yasuda Life Insurance Co’s holdings in UnitedHealth Group were worth $8,615,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Virtu Financial LLC boosted its holdings in shares of UnitedHealth Group by 16.0% in the third quarter. Virtu Financial LLC now owns 11,442 shares of the healthcare conglomerate’s stock valued at $3,044,000 after acquiring an additional 1,580 shares in the last quarter. Panagora Asset Management Inc. boosted its holdings in shares of UnitedHealth Group by 0.7% in the third quarter. Panagora Asset Management Inc. now owns 1,510,829 shares of the healthcare conglomerate’s stock valued at $401,941,000 after acquiring an additional 10,979 shares in the last quarter. FDx Advisors Inc. boosted its holdings in shares of UnitedHealth Group by 9.6% in the third quarter. FDx Advisors Inc. now owns 42,165 shares of the healthcare conglomerate’s stock valued at $11,218,000 after acquiring an additional 3,697 shares in the last quarter. Independent Advisor Alliance boosted its holdings in shares of UnitedHealth Group by 20.1% in the third quarter. Independent Advisor Alliance now owns 31,555 shares of the healthcare conglomerate’s stock valued at $8,307,000 after acquiring an additional 5,284 shares in the last quarter. Finally, Holderness Investments Co. boosted its holdings in shares of UnitedHealth Group by 2.4% in the third quarter. Holderness Investments Co. now owns 10,536 shares of the healthcare conglomerate’s stock valued at $2,803,000 after acquiring an additional 245 shares in the last quarter. Hedge funds and other institutional investors own 85.57% of the company’s stock.

Shares of NYSE:UNH opened at $269.18 on Friday. The company has a market cap of $267.97 billion, a P/E ratio of 26.73, a price-to-earnings-growth ratio of 1.60 and a beta of 0.76. UnitedHealth Group Inc has a 1-year low of $208.48 and a 1-year high of $287.94. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. The firm had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The firm’s revenue for the quarter was up 12.4% compared to the same quarter last year. During the same period last year, the firm posted $2.66 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Inc will post 12.82 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date is Friday, November 30th. UnitedHealth Group’s payout ratio is 35.75%.

UNH has been the subject of several recent analyst reports. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a report on Wednesday, September 5th. Citigroup cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 price objective for the company. in a report on Monday, September 10th. ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 11th. Cowen initiated coverage on shares of UnitedHealth Group in a report on Monday, September 17th. They issued an “outperform” rating and a $308.00 price objective for the company. Finally, Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 18th. Two analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $292.48.

In related news, Director Richard T. Burke sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 12th. The shares were sold at an average price of $263.41, for a total transaction of $5,268,200.00. Following the completion of the sale, the director now directly owns 1,720,112 shares in the company, valued at $453,094,701.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kenneth Irwin Shine sold 163 shares of the firm’s stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $274.83, for a total transaction of $44,797.29. The disclosure for this sale can be found here. Insiders have sold 34,395 shares of company stock valued at $9,186,302 over the last 90 days. 0.87% of the stock is currently owned by insiders.

TRADEMARK VIOLATION WARNING: This article was first posted by Transcript Daily and is owned by of Transcript Daily. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at https://transcriptdaily.com/2018/12/08/unitedhealth-group-inc-unh-is-meiji-yasuda-life-insurance-cos-9th-largest-position.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Why do corrections happen?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply